Cite
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
MLA
Tamari, Roni, et al. “A Simple Prognostic System in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation: A CIBMTR/EBMT Analysis.” Blood Advances, vol. 7, no. 15, Aug. 2023, pp. 3993–4002. EBSCOhost, https://doi.org/10.1182/bloodadvances.2023009886.
APA
Tamari, R., McLornan, D. P., Ahn, K. W., Estrada-Merly, N., Hernández-Boluda, J. C., Giralt, S., Palmer, J., Gale, R. P., DeFilipp, Z., Marks, D. I., van der Poel, M., Verdonck, L. F., Battiwalla, M., Diaz, M. A., Gupta, V., Ali, H., Litzow, M. R., Lazarus, H. M., Gergis, U., … Saber, W. (2023). A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis. Blood Advances, 7(15), 3993–4002. https://doi.org/10.1182/bloodadvances.2023009886
Chicago
Tamari, Roni, Donal P McLornan, Kwang Woo Ahn, Noel Estrada-Merly, Juan Carlos Hernández-Boluda, Sergio Giralt, Jeanne Palmer, et al. 2023. “A Simple Prognostic System in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation: A CIBMTR/EBMT Analysis.” Blood Advances 7 (15): 3993–4002. doi:10.1182/bloodadvances.2023009886.